Knowledge Action Portal on NCDs

6 Resources
Short
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> TRANSITION FROM A DONOR-SUPPORTED PROJECT TO A NATIONAL DIABETES PROGRAMME: LESSONS FROM TANZANIA <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI)

TRANSITION FROM A DONOR-SUPPORTED PROJECT TO A NATIONAL DIABETES PROGRAMME: LESSONS FROM TANZANIA

Briefs & Fact Sheets

09 Apr 2024

&nbsp;In 2019 a review was published on the impact of insulin donation programmes in ten low- and middle-income countries (LMIC) over the period 2009-2015.&nbsp; This study led to the formulation of a ten-step process for the transition from a donation-supported project towards a national diabetes programme. Tanzania has been in the process of such a transition since 2005. Despite some remaining c...

Briefs & Fact SheetsDiabetesMultisectoral ActionMultistakeholder CollaborationAccess to essential medicines and services
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Prices People Pay for Glargine Insulin <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI)

Prices People Pay for Glargine Insulin

Briefs & Fact Sheets

09 Apr 2023

Between 10 March and 20 April 2023, the ACCISS Study took a global snapshot of the prices people currently pay for glargine insulin and its affordability.&nbsp; Individuals from 47 countries collected the full price for all glargine products found in their closest private pharmacy and/or public sector pharmacy. While these prices should not be considered representative of the country (as inter-cou...

Briefs & Fact SheetsDiabetesMultisectoral ActionAccess to essential medicines and services

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> POOLED PROCUREMENT OF INSULIN AND ASSOCIATED SUPPLIES : Analysis of Mechanisms and their Applicability for Small State Countries or Countries with Limited Needs <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI)

POOLED PROCUREMENT OF INSULIN AND ASSOCIATED SUPPLIES : Analysis of Mechanisms and their Applicability for Small State Countries or Countries with Limited Needs

Report

09 Apr 2022

The objective of the study is to assess whether multi-country pooled procurement (tendering/purchasing/framework agreements or other) and/or information sharing initiatives could be beneficial for small lower-income nations for the purchasing of insulin, insulin syringes, blood glucose meters and blood glucose test strips, using the Pacific as a case study.

ReportDiabetesMultisectoral ActionMultistakeholder CollaborationAccess to essential medicines and services

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Management of type 1 diabetes in low- and middle- income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI), University of Geneva University of Geneva and Geneva University Hospitals

Management of type 1 diabetes in low- and middle- income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania

Publication

09 Apr 2022

Abstract Aims: To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Peru and Tanzania. Methods:&nbsp;The Rapid Assessment Protocol for Insulin Access, a multi-level as- sessment of the health system, was implemented in Kyrgyzstan, Mali, Peru and Tanzania using document reviews, site visits and interviews to assess the delivery of care and access to...

PublicationDiabetesMultisectoral ActionMultistakeholder CollaborationAccess to essential medicines and services

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> GUIDELINES FOR PROCUREMENT OF INSULINS AND ASSOCIATED SUPPLIES   <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI)

GUIDELINES FOR PROCUREMENT OF INSULINS AND ASSOCIATED SUPPLIES  

Report

09 Apr 2021

The objective of these ACCISS guidelines is to provide guidance to LMICs and specifically public sector procurers on how to improve procurement of insulins and associated supplies.&nbsp; You can also download the companion list of insulin products and international distributors (updated 2024) here.

ReportDiabetesMultisectoral ActionMultistakeholder CollaborationAccess to essential medicines and services

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> The Role of Health Technology Assessment in Medicine Pricing and Reimbursement <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Health Action International (HAI)

The Role of Health Technology Assessment in Medicine Pricing and Reimbursement

Briefs & Fact Sheets

27 Nov 2018

This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).

Briefs & Fact SheetsAccess to essential medicines and servicesDigital health and innovation

Access

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Read More